4//SEC Filing
MILLS ROBERT S 4
Accession 0001213900-20-042771
CIK 0001733413other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:05 PM ET
Size
8.7 KB
Accession
0001213900-20-042771
Insider Transaction Report
Form 4
MILLS ROBERT S
Director
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2020-12-11−22,794→ 219,719 totalExercise: $2.50From: 2019-04-06Exp: 2028-04-06→ Common Stock (22,794 underlying) - Exercise/Conversion
Common Stock
2020-12-11$2.50/sh+22,794$56,985→ 38,774 total - Sale
Common Stock
2020-12-11$14.58/sh−22,794$332,337→ 15,980 total
Footnotes (2)
- [F1]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- [F2]40,000 shares of the option vested and became exercisable on April 6, 2019.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001240140
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:05 PM ET
- Size
- 8.7 KB